IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Pernix Therapeutics Hldgs in

CUSIP: 71426V908 | 4 institutional holders

Quarters

Q3 2016Q2 2016Q4 2015Q3 2015Q2 2015
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile